ArticleBiomedicines2022

Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment.

Manuel Morales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.